Alto Neuroscience
Clinical trials sponsored by Alto Neuroscience, explained in plain language.
-
Personalized depression drug shows promise in Mid-Stage trial
Disease control CompletedThis study tested whether ALTO-100, a new investigational medication, helps reduce symptoms of major depression. It involved 301 adults with moderate to severe depression, who took the drug either by itself or added to their current antidepressant for 6 weeks. Researchers measure…
Phase: PHASE2 • Sponsor: Alto Neuroscience • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
New depression drug shows promise in early testing
Symptom relief CompletedThis study tested a new drug called ALTO-203 for people with major depression, especially those who struggle with a lack of pleasure (anhedonia). It involved 69 participants who received either the drug or a placebo to see how it affected their mood and alertness, and to check it…
Phase: PHASE2 • Sponsor: Alto Neuroscience • Aim: Symptom relief
Last updated Mar 09, 2026 14:22 UTC